← All organizations

Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

Academic/Hospital

Also known as: Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Sep 30, 2021

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

comarum palustre

Phase 2 (1 own, 0 via acquisition)

simvastatin

Other trials (1 own, 0 via acquisition)

diphenhydramine

Indications

Studied for

Recent trials (7)

NCT05036174Reponsible party - principal investigatorN/ASep 30, 2021
NCT05036174Lead sponsorN/ASep 30, 2021
NCT03530930Lead sponsorPhase 4Jun 29, 2018
NCT03530930Reponsible party - principal investigatorPhase 4Jun 29, 2018
NCT03530930Overall official - principal investigatorPhase 4Jun 29, 2018
NCT04183387Lead sponsorPhase 2Sep 30, 2014
NCT04183387Reponsible party - principal investigatorPhase 2Sep 30, 2014

Details

Last known activity: Sep 30, 2021